Back to News
Market Impact: 0.2
Wall Street Analysts Believe Promis Neurosciences (PMN) Could Rally 292.95%: Here's is How to Trade
Source: zacks.com
Analyst InsightsAnalyst Estimates
Analysts’ mean price target for Promis Neurosciences (PMN) implies 293% upside, though the article cautions that this metric has not been reasonably effective. It says strong analyst agreement in raising earnings estimates may indicate upside in the stock.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
PMN0.35
More News
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Intel plunges on a major guidance miss. What went wrong — and how to proceed
- FedEx Freight delivers a much-needed quarterly beat. Where we stand on shares now
- We're cutting our Amazon price target after a tough quarter. But it isn't all bad
- We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
- Microsoft's latest earnings beat the Street. Here's what analysts are saying